Discover Astex
R&D
Partnering
Our People & Culture
- Career Opportunities
Media
Contact
Search
Menu Menu

You are here: Home1 / Posters2 / 20123 / AACR: Pharmacodynamic and anti-tumor activity of fragment-derived inhibitors...

AACR: Pharmacodynamic and anti-tumor activity of fragment-derived inhibitors of MetAP2

24 October 2012/in 2012, Discovery

https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2012-10-24 12:26:172016-11-24 12:58:12AACR: Pharmacodynamic and anti-tumor activity of fragment-derived inhibitors of MetAP2

© Astex Pharmaceuticals
All rights reserved

Useful links

Home
Sitemap
Privacy Policy
Terms of Use
Legal

Member of the Otsuka Group

Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small...2012 EORTC: Characterization of a Potent XIAP & cIAP1 Dual Antagonist in...